Akari Therapeutics, Plc (AKTX) Net income 2016–2025
Akari Therapeutics, Plc (AKTX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$17.3MFY2025 · since FY2016: -$18.1M → -$17.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$17.3M | +12.6% |
| FY2024 | -$19.8M | -97.8% |
| FY2023 | -$10.0M | +43.6% |
| FY2022 | -$17.7M | -1.9% |
| FY2021 | -$17.4M | -2.0% |
| FY2020 | -$17.1M | -1.4% |
| FY2019 | -$16.8M | +17.8% |
| FY2018 | -$20.5M | +42.1% |
| FY2017 | -$35.4M | -95.1% |
| FY2016 | -$18.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice